Last updated on October 2018

Fluarix / FluLaval / Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Influenza Vaccine | Influenza
  • Age: - 100 Years
  • Gender: Female

Inclusion Criteria:

A subject will be included in the Registry if all of the following criteria are met:

  • Exposure to GSK sIIVs occurs during pregnancy or within 28 days preceding conception.
  • Subject is a US resident.
  • A HCP is identified (name, address and phone number).
  • Subject can be identified (by GSK or HCP).

Data from registered subjects will be included in the analyses if the following criterion is met:

Pregnancy is ongoing and the outcome is unknown at the time of initial report.

Exclusion Criteria:

Data from registered subjects will not be included in the analyses if the following criterion is met:

Outcome of pregnancy is known at the time of initial report. Types of known outcomes include prenatal testing reports in which the results are abnormal or outside the reference range, indicating possible abnormality in the fetus.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.